Summit Therapeutics
SMMT
SMMT
203 hedge funds and large institutions have $1.65B invested in Summit Therapeutics in 2024 Q4 according to their latest regulatory filings, with 67 funds opening new positions, 75 increasing their positions, 37 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
11% less capital invested
Capital invested by funds: $1.85B → $1.65B (-$196M)
32% less call options, than puts
Call options by funds: $36.7M | Put options by funds: $53.9M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
203
Holding in Top 10
1
Calls
$36.7M
Puts
$53.9M
Top Buyers
| 1 | +$38.1M | |
| 2 | +$20M | |
| 3 | +$19M | |
| 4 |
Millennium Management
New York
|
+$14.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.9M |
Top Sellers
| 1 | -$23.8M | |
| 2 | -$9.26M | |
| 3 | -$8.27M | |
| 4 |
D.E. Shaw & Co
New York
|
-$6.53M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$6.24M |